Multiple strategies enhance the efficacy of MSCs transplantation for spinal cord injury

Biomed Pharmacother. 2023 Jan:157:114011. doi: 10.1016/j.biopha.2022.114011. Epub 2022 Nov 18.

Abstract

Spinal cord injury (SCI) is a serious complication of the central nervous system (CNS) after spine injury, often resulting in severe sensory, motor, and autonomic dysfunction below the level of injury. To date, there is no effective treatment strategy for SCI. Recently, stem cell therapy has brought hope to patients with neurological diseases. Mesenchymal stem cells (MSCs) are considered to be the most promising source of cellular therapy after SCI due to their immunomodulatory, neuroprotective and angiogenic potential. Considering the limited therapeutic effect of MSCs due to the complex pathophysiological environment following SCI, this paper not only reviews the specific mechanism of MSCs to facilitate SCI repair, but also further discusses the research status of these pluripotent stem cells combined with other therapeutic approaches to promote anatomical and functional recovery post-SCI.

Keywords: Immunoregulation; Mesenchymal stem cells; Neuroprotective effect; Spinal cord injury; Stem cell therapy.

Publication types

  • Review

MeSH terms

  • Humans
  • Mesenchymal Stem Cell Transplantation* / methods
  • Mesenchymal Stem Cells* / physiology
  • Recovery of Function
  • Spinal Cord
  • Spinal Cord Injuries* / therapy